Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
For clinically significant metabolic acidosis. Sold as Sodium Bicarbonate In Plastic Container, Sodium Bicarbonate. Every FDA application for this active ingredient: 3 branded and 16 generic.
As of Nov 15, 2026, FDA lists 19 applications for Sodium Bicarbonate (sold as Sodium Bicarbonate In Plastic Container, Sodium Bicarbonate), first approved Jun 3, 1986, with 0 new uses approved and 0 published complete response letters.
First approved: Jun 3, 1986
Applications: 19
New uses approved: 0
Complete response letters: 0
Medicare spending, 2025: $523K
Shortage: Current
Medicare Spending
CMS Part D and Part B, 2025, before manufacturer rebates; matched by generic name
Product
Part
Spending, 2025
Change
Beneficiaries
Sodium Bicarbonate
Part D
$523K
-8%
1,709
What Pharmacies Pay
Median price per unit across package codes in CMS's weekly NADAC survey, Nov 11, 2026, before rebates; see every drug's price change
SODIUM BICARBONATE 8.4% VIAL: $0.154 per MLGeneric · -7% in a year
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient.Drugs@FDA
Abbott
Fresenius Kabi USA
Baxter Hlthcare Corp